LSBPW

LakeShore Biopharma Warrants
LSBPW

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

31 hedge funds and large institutions have $3.07M invested in LakeShore Biopharma Warrants in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$185K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.68M
2
+$320K
3
+$240K
4
VAM
Valliance Asset Management
Hong Kong
+$117K
5
BP
BFAM Partners
Hong Kong
+$85.6K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.68M
2
$320K
3
$240K
4
$117K
5
$85.6K
6
$84K
7
$77.8K
8
$77.6K
9
$76.3K
10
$42.5K
11
$35.5K
12
$22.7K
13
$20K
14
$19.5K
15
$16K
16
$15.6K
17
$15.6K
18
$15.6K
19
$15.6K
20
$15.6K
21
$15.2K
22
$13.5K
23
$12K
24
$7.35K
25
$6.05K
1
2